Some medical devices could get faster approval with new FDA rules

By Gayle S. Putrich
Staff Reporter

Published: April 22, 2014 7:41 pm ET
Updated: April 22, 2014 7:46 pm ET

Related to this story

Topics Medical, Public Policy, United States

WASHINGTON — The U.S. Food and Drug Administration is proposing an expedited approval for medical devices for devices aimed at the diagnosis or treatment of patients with serious conditions that would otherwise go untreated.

Introduced April 22, the “Expedited Access Premarket Approval Application for Unmet Medical Needs for Life Threatening or Irreversibly Debilitating Diseases or Conditions,” or “Expedited Access PMA” would include earlier and more engaged interaction with senior-level FDA staff which the agency believes will lead to faster patient access to safe medical devices. 

“We are excited to offer a proposed program for expedited access for certain high-risk medical devices,” said Dr. Jeffrey Shuren, director of the FDA’s Center for Devices and Radiological Health. “The program allows manufacturers to engage early and often with the agency. We expect most devices that enter this program will be in the pre-clinical trial phase.” 

The program builds on the FDA’s experience with expedited review programs for pharmaceuticals and would be open to devices that are intended to treat or diagnose a life-threatening or irreversibly-debilitating disease or condition for which no approved alternative treatment or diagnostic equipment exists, or for a breakthrough technology that provides a clinical advantage over existing technology or approved alternatives. Participating device manufacturers must have an acceptable data development plan that has been approved by the FDA.

According to the agency, the Expedited Access PMA is not a new pathway to market, but a collaborative approach to facilitate product development under existing regulations. While other existing device programs have focused on reducing the time for pre-market review, the new approach, if adopted, would aim to also reduce the time associated with product development.

In a separate draft guidance, the also outlined the agency’s current policy on when data can be collected after product approval and what actions are available to the FDA if approval conditions, such as post-market data collection, are not met.

Included in the guidance is advice on the use of surrogate or independent markers to support approval, similar to the data points used for accelerated approval of prescription drugs.

Both proposals are open for public comment at www.fda.gov/medicaldevices


Comments

Some medical devices could get faster approval with new FDA rules

By Gayle S. Putrich
Staff Reporter

Published: April 22, 2014 7:41 pm ET
Updated: April 22, 2014 7:46 pm ET

Post Your Comments


Back to story


More stories

Image

Judge limits scope of jury verdict against JM Eagle

December 19, 2014 2:30 pm ET

A federal judge in Los Angeles said Dec. 18 that last year's jury verdict issued against J-M Manufacturing Co. — now JM Eagle — for...    More

Image

Jarden hiring for new plastics plant

December 19, 2014 1:45 pm ET

Consumer products conglomerate Jarden Corp. is hiring plastics technicians for a new operation in Erlanger, Ky.    More

Image

Antimicrobial polymers firm TiFiber launching pilot production in Ark.

December 19, 2014 10:58 am ET

TiFiber Inc., which makes synthetic compounds to control dangerous microorganisms, will locate a pilot production facility and its future company...    More

Image

Spray PU foam aids in NASA launch

December 19, 2014 9:22 am ET

NASA's test of the Orion spacecraft earlier this month took advantage of spray polyurethane foam insulation from North Carolina Foam Industries...    More

Auto supplier M-Tek relocating headquarters

December 18, 2014 3:37 pm ET

M-Tek Inc., a subsidiary of Japanese automotive supplier Kasai Kogyo Co. Ltd., will build a new North American corporate headquarters in Murfreesboro,...    More

Market Reports

Flexible Packaging Trends in North America

Our latest RESEARCH report examines trends in FLEXIBLE PACKAGING impacting the North American market including a review of economic conditions, key drivers of growth, materials pricing, M&A activity, sustainability challenges and the outlook for 2015.

Learn more

Plastics in Brazil - State of the Industry Report

This in-depth report examines the Brazilian plastics industry from a historical and geographical context. Our analysts provide insight on economic trends and forecasts, growing manufacturing sectors that utilize plastics, private investment opportunities, market environment challenges, and innovations in R&D.

Data tables and charts on producer prices, trade, plastics production and end market indicators is also included.

Learn more

Plastics Recycling Trends in North America

This report is a review and analysis of the North American Plastics Recycling Industry, including key trends and statistics based on 2013 performance. We examine market environment factors, regulatory issues, industry challenges, key drivers and emerging trends in post-consumer and post-industrial recycling.

Learn more

Upcoming Plastics News Events

January 14, 2015 - January 14, 2015Plastics in Automotive

February 4, 2015 - February 6, 2015Plastics News Executive Forum 2015

June 2, 2015 - June 3, 2015Plastics Financial Summit - Chicago 2015

September 16, 2015 - September 18, 2015Plastics Caps & Closures - September 2015

October 27, 2015 - October 29, 2015Plastics Financial Summit - New York - 2015

More Events